ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Castle Biosciences Inc

Castle Biosciences Inc (CSTL)

18.0183
-3.23
( -15.21% )
Updated: 11:59:23

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
18.0183
Bid
17.99
Ask
18.07
Volume
552,161
17.36 Day's Range 19.4899
12.07 52 Week Range 25.91
Market Cap
Previous Close
21.25
Open
19.132
Last Trade
1
@
18.0178
Last Trade Time
11:59:21
Financial Volume
$ 9,853,691
VWAP
17.8457
Average Volume (3m)
253,988
Shares Outstanding
27,607,183
Dividend Yield
-
PE Ratio
-8.61
Earnings Per Share (EPS)
-2.08
Revenue
219.79M
Net Profit
-57.47M

About Castle Biosciences Inc

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
1970
Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $21.25. Over the last year, Castle Biosciences shares have traded in a share price range of $ 12.07 to $ 25.91.

Castle Biosciences currently has 27,607,183 shares outstanding. The market capitalization of Castle Biosciences is $586.65 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -8.61.

CSTL Latest News

Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE)1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2024, the Compensation Committee of its...

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and...

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular...

New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis

In the study, patients with DecisionDx-SCC Class 2B test results, predicted to have the highest risk of metastasis by the test, who were treated with adjuvant radiation therapy (ART) had 50...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.2517-15.287729196121.2721.9817.3636475921.46697458CS
4-4.4418-19.776403488922.460123.9617.3629273621.99278559CS
12-2.6917-12.997102848920.7125.9117.3625398822.71259016CS
26-2.1217-10.534756703120.1425.9117.3624891022.11305286CS
524.548333.766146993313.4725.9112.0732482919.60579841CS
156-53.1417-74.679173693171.1678.5859.260127969526.14151435CS
260-1.9817-9.908520107.699.260125251134.15805657CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 4.7802
(122.33%)
18.93M
QLGNQualigen Therapeutics Inc
$ 0.30
(71.04%)
221.42M
INVZWInnoviz Technologies Ltd
$ 0.2499
(51.91%)
17.79k
XHGXChange TED Inc
$ 1.2601
(51.82%)
59.9M
SHOTWSafety Shot Inc
$ 0.25
(38.89%)
538
VEVVicinity Motor Corporation
$ 0.3957
(-29.84%)
208.58k
CYNCYNGN Inc
$ 4.22
(-21.42%)
246.19k
JEWLAdamas One Corporation
$ 0.3689
(-20.07%)
685.08k
PRTGPortage Biotech Inc
$ 0.1455
(-19.39%)
6.24M
ABLVAble View Global Inc
$ 0.8811
(-18.42%)
34
QLGNQualigen Therapeutics Inc
$ 0.30
(71.04%)
221.42M
MAXNMaxeon Solar Technologies Ltd
$ 0.2279
(31.28%)
183.37M
NVDANVIDIA Corporation
$ 126.97
(-1.02%)
105.38M
TSLATesla Inc
$ 248.57
(0.88%)
82.6M
SQQQProShares UltraPro Short QQQ
$ 7.485
(-2.67%)
63.71M

Discussion

View Full Feed
everton44 everton44 4 minutes ago
IOVA from the CEO himself said they are selling all their stock and are out of money. I wonder why this is still trading tbh.
IOVA
yielddude yielddude 4 minutes ago
my picks DD

NEM - gold stock, large producer, decent divvy
FTCO - gold stock, 11% divvy, strong balance sheet, down because delay in permit approval, unknown when they will be approved
GILT - my weakest pick, just threw it in there
CSPI - did it for tomorrow. but
ANVS BCRX FTCO
Monksdream Monksdream 4 minutes ago
BDTX under $5
https://investorshub.advfn.com/uimage/uploads/2024/7/5/fgkpeIMG_9273.gif
BDTX
Dingbatt Dingbatt 5 minutes ago
Money
Im an earthling, cant live on Mercury above 200 Degrees cant live on Venus 500 degrees cant live on Mar 80 below zero No interest sitting on the moon with Musk or Virgin Gallactic no interest diving on the Titanic, but still interested in Fort Le Comb, and Bre-x Mine or any other mine
BITCF
LetGoodTimesRoll LetGoodTimesRoll 5 minutes ago
Goooood $RNVA $FOXO NYSE KABOOM BOOM $$$$$$$$$ afternoon!!!!!!
FOXO RNVA
diggitydoodle diggitydoodle 5 minutes ago
WOW!
3 nice buys in a row...9, 9 & 4 mill.
Hmm.....
RNVA!!!$$$$$???????
RNVA
glenn1919 glenn1919 5 minutes ago
MULN...........................https://www.stockscores.com/charts/charts/?ticker=MULN
MULN
Jaxxm Jaxxm 5 minutes ago
MAXN multi dollars share price big possibility
MAXN
Runners123 Runners123 6 minutes ago
SMR longer term but could be a great retirement investment,,, portable nuclear power.
SMR
Nebuchadnezzar Nebuchadnezzar 6 minutes ago
-VIZC-

potential runner?
VIZC
Reanimator Reanimator 6 minutes ago
You do realize you just proved my point, right?

"The company continues to diligently pursue commercial material supply licensing agreements in 2024" is worlds away from "contract negotiations are ongoing, with what ML says are large companies."

You're not a child. You u
LWLG
Dell_Griffith Dell_Griffith 6 minutes ago
Looks like Amorphology is looking to go public. They merged the CA entity in during 2020 to a Delaware reincorporation and did a bunch of stock restatements and re-allocations relatively recently -

Entity Details
File Number: 6664702 Incorporation Date / Formation Date: 12/15/2
LQMT
RickNagra RickNagra 6 minutes ago
https://www.icba.org/newsroom/blogs/main-street-matters/2023/09/06/after-15-years-the-federal-government-should-end-its-conservatorship-of-fannie-mae-and-freddie-mac
FNMA
everton44 everton44 7 minutes ago
IOVA likely to run out of funds by mid 2025, look for Bankruptcy of just the cease of business
IOVA
glenn1919 glenn1919 7 minutes ago
MULN.............................https://www.stockscores.com/charts/charts/?ticker=MULN
MULN
Nebuchadnezzar Nebuchadnezzar 7 minutes ago
time to buy puts, this move is over done
META
go seek go seek 7 minutes ago
I sense that market sentiment towards RVNC has turned positive. It’s about time… DAXXIFY, Fast onset, Long duration and the Look!
RVNC
JusDePomme JusDePomme 7 minutes ago
He cannot disclose further than watch in public domain for filing! He understand late !
RSPI
vuletini vuletini 8 minutes ago
He did appear as promised but in a Superman like costume
SHIBUSD
Runners123 Runners123 8 minutes ago
MCRB
MCRB
GigantorX GigantorX 8 minutes ago
I'll buy big in the trips .000s. This is headed there in a hurry.
BLEG
boston745 boston745 8 minutes ago
Amazon's electric delivery vans keep catching on fire
Chargers have been blamed for fires before, either due to improper home wiring or inadequate cooling

EV fires, while severe, aren’t as common as some naysayers predicted when electric power first started gaining popularity.
TSLA
Monksdream Monksdream 8 minutes ago
NEW highs in which I have positions
AAPL AMZN APP COST FICO MSFT NFLX ORCL VRSK
AAPL AMZN MSFT

Your Recent History

Delayed Upgrade Clock